XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications

XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications

Saved in:

Bibliographic Details
Main Authors:	Tingting Qin, Jingya Wang, Dingzhi Huang
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2025-06-01
Series:	Cancer Biology & Medicine
Online Access:	https://www.cancerbiomed.org/content/22/6/543
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modulation of anti-tumour immunity by XPO1 inhibitors
by: Jack G. Fisher, et al.
Published: (2025-04-01)

Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7‐driven Small Cell Lung Cancer
by: Tingting Qin, et al.
Published: (2025-04-01)

RAN potentiates nuclear export of phosphorylated AMPK, reshaping lipid metabolism and impairing immune efficacy in lung adenocarcinoma
by: Qingwu Du, et al.
Published: (2025-06-01)

Mutations of Key Functional Residues in CRM1/XPO1 Differently Alter Its Intranuclear Localization and the Nuclear Export of Endogenous Cargos
by: Miren Josu Omaetxebarria, et al.
Published: (2024-12-01)

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis
by: Liyan Yu, et al.
Published: (2023-01-01)

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer
by: Ximo Zhang, et al.
Published: (2025-01-01)

Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication
by: Masmudur M. Rahman, et al.
Published: (2025-02-01)

Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor
by: Junying Wang, et al.
Published: (2025-01-01)

Unraveling the role of HDAC3 as an immunotherapy prognostic biomarker and therapeutic target in advanced non-small cell lung cancer
by: Liyuan Dai, et al.
Published: (2025-06-01)

A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets
by: Lin Li, et al.
Published: (2025-01-01)

Biomarkers for non-small cell lung cancer immunotherapy
by: D. A. Kharagezov, et al.
Published: (2021-09-01)

Advances in biomarkers for immunotherapy in small-cell lung cancer
by: Hui Li, et al.
Published: (2024-12-01)

Novel prognostic biomarkers in small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications
by: Yuting Li, et al.
Published: (2025-05-01)

Unlocking the therapeutic potential of antibody–drug conjugates in targeting molecular biomarkers in non-small cell lung cancer
by: Shruti Soni, et al.
Published: (2025-03-01)

Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities
by: Huiyu Wang, et al.
Published: (2025-08-01)

tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer
by: Bo Zhang, et al.
Published: (2025-01-01)

Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5
by: Zhi-Wen Wang, et al.
Published: (2025-06-01)

Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic implications
by: Lili Li, et al.
Published: (2025-08-01)

Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer
by: Nan Zhang, et al.
Published: (2025-01-01)

Single-Nucleotide Polymorphisms in XPO5 are Associated with Noise-Induced Hearing Loss in a Chinese Population
by: Ning Wang, et al.
Published: (2020-01-01)

XPO1 serves as a prognostic marker involving AKT/MAPK/TGFBR1 pathway in OSCC
by: Ying Han, et al.
Published: (2024-08-01)

Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report
by: Yang Zhang, et al.
Published: (2025-01-01)

Non-coding RNAs and Hippo signaling in non-small cell lung cancer: emerging roles as biomarkers and therapeutic targets
by: Mohammadamin Joulani, et al.
Published: (2025-07-01)

Biomarkers for immunotherapy resistance in non-small cell lung cancer
by: Catriona Rother, et al.
Published: (2024-12-01)

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
by: Songting Shou, et al.
Published: (2025-01-01)

Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies
by: Dandan Guo, et al.
Published: (2025-03-01)

T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation
by: Yu Liu, et al.
Published: (2025-05-01)

JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases
by: Yimeng Dai, et al.
Published: (2025-03-01)

*Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions
by: Xuanlin Tao, et al.
Published: (2025-05-01)

Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality
by: Qianqian Guo, et al.
Published: (2025-05-01)

Biomarkers in Diabetic Retinopathy and the Therapeutic Implications
by: Katarzyna Zorena, et al.
Published: (2013-01-01)

SGSM1 as a pan-cancer biomarker: multi-omics insights into immune regulation, prognostic value, and therapeutic implications
by: Dali Wu, et al.
Published: (2025-06-01)

Acute cerebral small vessel disease: Classification, mechanism, and therapeutic implications
by: Yuying Yan, et al.
Published: (2024-11-01)

Osteopontin is a prognostic biomarker in non-small cell lung cancer
by: Ane Kongsgaard, et al.
Published: (2013-11-01)

Investigation of biomarkers and associated molecular mechanism shared between colorectal cancer and lung adenocarcinoma
by: Kun Gao, et al.
Published: (2025-08-01)

Long interspersed nuclear element 1 methylation in non-small cell lung cancer: implications for diagnosis, prognosis, and therapeutic targeting
by: Dileesha Prabani Wanasundara Arachchillage, et al.
Published: (2025-07-01)

Redox regulation of cancer stem cells: Biology and therapeutic implications
by: Min Du, et al.
Published: (2024-12-01)

Multiomics Analysis of Exportin Family Reveals XPO1 as a Novel Target for Clear Cell Renal Cell Carcinoma
by: Yanhong Hao, et al.
Published: (2025-01-01)

Recent advances in therapeutic strategies for non-small cell lung cancer
by: Po-Lan Su, et al.
Published: (2025-03-01)

Ferroptosis: Therapeutic Potential and Strategies in Non-Small Cell Lung Cancer
by: Ying Lei, et al.
Published: (2025-05-01)